Hercules Capital Inc. (HTGC)
Hercules Capital (HTGC) Advances While Market Declines: Some Information for Investors
The latest trading day saw Hercules Capital (HTGC) settling at $16.37, representing a +1.61% change from its previous close.
Hercules Capital (HTGC) Stock Dips While Market Gains: Key Facts
Hercules Capital (HTGC) reached $15.69 at the closing of the latest trading day, reflecting a -1.26% change compared to its last close.
Hercules Capital (HTGC) Advances While Market Declines: Some Information for Investors
In the closing of the recent trading day, Hercules Capital (HTGC) stood at $15.58, denoting a +2.23% move from the preceding trading day.
Brokers Suggest Investing in Hercules Capital (HTGC): Read This Before Placing a Bet
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Hercules Capital: This 12% Yield Is My Top Pick For The Back Half
Hercules Capital stands out among BDCs for its resilient, venture-focused portfolio and minimal AI disruption risk. HTGC maintains strong credit quality, with only 0.1% of its portfolio on non-accrual and a 12% yield, supporting a Strong Buy rating. Portfolio composition is 44% healthcare/life sciences and 35% application software, with high barriers to entry and AI beneficiaries.
Hercules Capital Faces Its Own 12 Labors
Hercules Capital is trading at a 30% premium to NAV, down from 72% in 2024, reflecting compressed sentiment around technology-focused BDCs. HTGC is paying out a 12.1% dividend yield, with a $0.40 base and a $0.07 supplemental quarterly dividend. The base dividend was 120% covered by first-quarter net investment income. Portfolio credit quality remains robust, with nonaccruals at fair value at just 0.1% of the total investment portfolio as of the end of the first quarter.
Hercules Capital (HTGC) Ascends While Market Falls: Some Facts to Note
Hercules Capital (HTGC) closed the most recent trading day at $15.65, moving +1.03% from the previous trading session.
Hercules Capital: Attractive Valuation And Growth Potential
Hercules Capital is a strong buy, trading at a rare 28.4% NAV premium versus its 5-year average of 49.36%. HTGC offers a 12.3% dividend yield, with distributions well covered by net investment income and supported by $149.1M in spillover income. The portfolio is conservatively structured, with 98% floating-rate senior secured loans and non-accruals at just 0.1% of fair value.
Hercules Capital (HTGC) Down 7.4% Since Last Earnings Report: Can It Rebound?
Hercules Capital (HTGC) reported earnings 30 days ago. What's next for the stock?
Hercules Capital Q1 Earnings Call Highlights
Hercules Capital NYSE: HTGC reported record first-quarter 2026 originations and total investment income while emphasizing stable credit quality and strong liquidity amid heightened market volatility.
Hercules Capital: Don't Let The SaaS Panic Blind You To 120% Dividend Coverage
Following February's pullback, HTGC shares appear oversold relative to historical P/NAV metrics. The Q1 2026 earnings report exceeded analysts' expectations: NII of $0.48 and total revenue of $141.5 million confirm the robustness of the business model. Management is actively diversifying SaaS risks by reallocating capital to Biotech, Defense Tech, and Space Tech.
Hercules Capital: Great Portfolio At A Bad Price
Hercules Capital remains a hold due to its 37% premium to book value, limiting total return potential despite strong fundamentals. HTGC's portfolio quality is exceptional, with only 0.9% in 4-5-rated investments and a best-in-period weighted rating of 2.11 as of Q1 2026. Management's conservative underwriting and focus on high switching-cost software companies mitigate sector risks, with AI seen as a net positive.
